morphine-3-glucuronide and Prostatic-Neoplasms

morphine-3-glucuronide has been researched along with Prostatic-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for morphine-3-glucuronide and Prostatic-Neoplasms

Article	Year
Changing M3G/M6G ratios and pharmacodynamics in a cancer patient during long-term morphine treatment. Journal of pain and symptom management, 2002, Volume: 23, Issue:2 A cancer patient receiving long-term oral sustained-release morphine treatment and periodically presenting with unusually high plasma M3G/M6G ratios is described. We found the patient's formation of M6G more unstable and perhaps delayed compared to the formation of M3G. There is no apparent explanation for this phenomenon and the high M3G/M6G ratios had no implications for the patient's pain experience or side effects from the morphine treatment. Topics: Analgesics, Opioid; Central Nervous System Stimulants; Humans; Male; Middle Aged; Morphine; Morphine Derivatives; Pain; Prostatic Neoplasms; Time Factors	2002

Article

Year

Changing M3G/M6G ratios and pharmacodynamics in a cancer patient during long-term morphine treatment.

Journal of pain and symptom management, 2002, Volume: 23, Issue:2

A cancer patient receiving long-term oral sustained-release morphine treatment and periodically presenting with unusually high plasma M3G/M6G ratios is described. We found the patient's formation of M6G more unstable and perhaps delayed compared to the formation of M3G. There is no apparent explanation for this phenomenon and the high M3G/M6G ratios had no implications for the patient's pain experience or side effects from the morphine treatment.

Topics: Analgesics, Opioid; Central Nervous System Stimulants; Humans; Male; Middle Aged; Morphine; Morphine Derivatives; Pain; Prostatic Neoplasms; Time Factors

2002